Literature DB >> 9694403

Protective effect of melatonin in a model of traumatic brain injury in mice.

C Mésenge1, I Margaill, C Verrecchia, M Allix, R G Boulu, M Plotkine.   

Abstract

The pineal hormone melatonin has recently been shown to exert neuroprotective activity in a variety of experimental neuropathologies in which free radicals are involved. This neuroprotective effect has been attributed to the antioxidant properties of melatonin. Considering that free radicals also play a deleterious role in traumatic brain injury (TBI), the purpose of the present study was to determine whether melatonin would have a beneficial effect in this pathology. Head injury was induced in mice and the neurological deficit was evaluated at 24 hr by a grip test. In this model, the free radical scavenger, alpha-phenyl-tert-butyl-nitrone (2 x 100 mg/kg, i.p.) given 5 min and repeated at 4 hr after TBI was neuroprotective. Melatonin (1.25 mg/kg, i.p.) given 5 min and repeated at 1, 2, and 3 hr after head trauma also significantly reduced the neurological deficit. This beneficial effect was not due to melatonin-induced hypothermia since repeated treatment with melatonin did not modify the colonic temperature of mice. This study shows that melatonin exerts a beneficial effect on the neurological deficit induced by traumatic brain injury in mice. The mechanisms of this neuroprotection remains to be established, and more particularly, the contribution of the antioxidant activity of melatonin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694403     DOI: 10.1111/j.1600-079x.1998.tb00384.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  23 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Differential effects of early postinjury treatment with neuroprotective drugs in a mouse model using diffuse reflectance spectroscopy.

Authors:  Ariel Shochat; David Abookasis
Journal:  Neurophotonics       Date:  2015-01-22       Impact factor: 3.593

Review 3.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 4.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 5.  Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke.

Authors:  Hai-Jian Wu; Cheng Wu; Huan-Jiang Niu; Kun Wang; Lian-Jie Mo; An-Wen Shao; Brandon J Dixon; Jian-Min Zhang; Shu-Xu Yang; Yi-Rong Wang
Journal:  Cell Mol Neurobiol       Date:  2017-01-28       Impact factor: 5.046

Review 6.  Crosstalk Between Endoplasmic Reticulum Stress, Oxidative Stress, and Autophagy: Potential Therapeutic Targets for Acute CNS Injuries.

Authors:  Venkata Prasuja Nakka; Phanithi Prakash-Babu; Raghu Vemuganti
Journal:  Mol Neurobiol       Date:  2014-12-09       Impact factor: 5.590

Review 7.  Domoic acid-induced neurotoxicity in the hippocampus of adult rats.

Authors:  Ananth Chandrasekaran; Gopalakrishnakone Ponnambalam; Charanjit Kaur
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

8.  Changes in vascularity of cartilage endplate of degenerated intervertebral discs in response to melatonin administration in rats.

Authors:  Mehmet Turgut; Serap Uslu; Ayşegül Uysal; Mine Ertem Yurtseven; Hatice Ustün
Journal:  Neurosurg Rev       Date:  2003-05       Impact factor: 3.042

9.  Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury.

Authors:  Leonardo Lorente; María M Martín; Pedro Abreu-González; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; José M Lorenzo; Ismael Molina; Alejandro Jiménez
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

Review 10.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.